If it does not smell right, it is probably not right.
I challenge anybody to match that record. But I think it is a clear indication of how much regard the Director is held in.
I am pleased to have a President who set out a marker.
I would be very much opposed to that. I don't think that is fair to those companies, and I think it would discourage investment later.
But, look, we know China is sort of a bad actor. They will steal anything that is not nailed down.
The United States' investments in biomedical research and medical countermeasures have paved the way for the fastest vaccine ever developed ...
Operation Warp Speed, in my mind, remains one of the most undervalued achievements of the last administration.
This committee, I think, has done an exceptional job under our chairman in this regard.
I am very supportive of the President's topline proposal here.
I am just arguing for we are going a little fast here before we actually have this thing worked through.
I very much appreciate that and commend you for your diligence and urge you to double down on that.
I believe, based upon the experience we have had with COVID-19... we had no difficulty figuring out how to invest those in vaccines, in ther...
As the chair, you are never out of time, number one.
I am very proud of what this committee did, and I am very proud of what the NIH, more profoundly, accomplished in this year, not only for us...
Any sort of agreement that is a treaty agreement, or is an agreement for changing tax policy, would require bipartisan cooperation and engag...
I would expect that to be the case. I, again, would need to be briefed on the issue.
Larry Summers even warning that this legislation was the 'least responsible macroeconomic policy we've had in the last 40 years.'
There has been some conversation that the administration is examining ways to be able to change tax policies without going through Congress.
